💊

Drugs Recalls

Prescription and over-the-counter medications

17,685 Total Recalls

Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.

Sep 5, 2017 Prescription Drugs View Details →

Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.

Oct 13, 2017 Prescription Drugs Nationwide View Details →

Failed dissolution specifications; all lots within expiry are being recalled due to out of specification dissolution results.

Oct 25, 2017 Prescription Drugs Nationwide View Details →

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sibutramine, phenolphthalein, and n-desmethyl sibutramine, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.

Oct 6, 2017 Prescription Drugs Nationwide View Details →